Lipomodelling at Chesterfield Royal Hospital: Service review in a District General Hospital using Lipomodelling Guidelines for Breast Surgery (2012).
Association of Breast Surgery ePoster Library. Hodgkins K. 05/13/19; 257195; P153
Kathryn Hodgkins
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
P153
Topic: Surgical techniques
Introduction: After the introduction of Lipomodelling, a useful tool in the breast surgeon's armoury, in 2015, a service evaluation was undertaken using the joint Lipomodelling Guidelines for Breast Surgery (2012). Methods :Theatre diaries, 2015 to 2017, were used to identify patients who underwent lipomodelling. Patient's complete hospital records were reviewed. Results: 61 of 70 patients' data was available for review. Median age 53yrs (range20-76). 55(90%) underwent the procedure for cancer; 5(8%) for risk reduction; and 1(1.6%) for cosmesis. 24(39%) received written information. The median number of procedures was 2(range1-4). Younger patients underwent more procedures. (<39yrs:2.8; >60yrs:1.4). 53(87%) noted some improvement; 37(61%) significant improvement. 34(55.7%) had no complications described in the guideline; there was 1(1.6%) infection and 9(15%) experienced post-operative pain. Smokers 9(15%) needed more procedures than non-smokers (2.7 vs 1.8) and had less significant improvements (55.6% vs 68.2%). Smokers had more fat harvested (358mls vs 229mls) and more fat used (219mls:61.9% vs 142mls:60.3%). Patients with significant improvements had a larger fat volume harvested (255mls) and larger proportion used (174mls:63.6%). No local recurrence was recorded. Small group numbers limited statistical analysis. Conclusions: Our data agrees with current research, that smokers have worse outcomes. MDT consultation provides written information and thorough discussion by surgeons and breast care nurses but recorded with variability. Findings indicate broad adherence to guidance. The outcome for smokers raises questions about offering them lipomodelling and emphasises the need for smoking cessation advice in breast surgery units.
Topic: Surgical techniques
Introduction: After the introduction of Lipomodelling, a useful tool in the breast surgeon's armoury, in 2015, a service evaluation was undertaken using the joint Lipomodelling Guidelines for Breast Surgery (2012). Methods :Theatre diaries, 2015 to 2017, were used to identify patients who underwent lipomodelling. Patient's complete hospital records were reviewed. Results: 61 of 70 patients' data was available for review. Median age 53yrs (range20-76). 55(90%) underwent the procedure for cancer; 5(8%) for risk reduction; and 1(1.6%) for cosmesis. 24(39%) received written information. The median number of procedures was 2(range1-4). Younger patients underwent more procedures. (<39yrs:2.8; >60yrs:1.4). 53(87%) noted some improvement; 37(61%) significant improvement. 34(55.7%) had no complications described in the guideline; there was 1(1.6%) infection and 9(15%) experienced post-operative pain. Smokers 9(15%) needed more procedures than non-smokers (2.7 vs 1.8) and had less significant improvements (55.6% vs 68.2%). Smokers had more fat harvested (358mls vs 229mls) and more fat used (219mls:61.9% vs 142mls:60.3%). Patients with significant improvements had a larger fat volume harvested (255mls) and larger proportion used (174mls:63.6%). No local recurrence was recorded. Small group numbers limited statistical analysis. Conclusions: Our data agrees with current research, that smokers have worse outcomes. MDT consultation provides written information and thorough discussion by surgeons and breast care nurses but recorded with variability. Findings indicate broad adherence to guidance. The outcome for smokers raises questions about offering them lipomodelling and emphasises the need for smoking cessation advice in breast surgery units.
P153
Topic: Surgical techniques
Introduction: After the introduction of Lipomodelling, a useful tool in the breast surgeon's armoury, in 2015, a service evaluation was undertaken using the joint Lipomodelling Guidelines for Breast Surgery (2012). Methods :Theatre diaries, 2015 to 2017, were used to identify patients who underwent lipomodelling. Patient's complete hospital records were reviewed. Results: 61 of 70 patients' data was available for review. Median age 53yrs (range20-76). 55(90%) underwent the procedure for cancer; 5(8%) for risk reduction; and 1(1.6%) for cosmesis. 24(39%) received written information. The median number of procedures was 2(range1-4). Younger patients underwent more procedures. (<39yrs:2.8; >60yrs:1.4). 53(87%) noted some improvement; 37(61%) significant improvement. 34(55.7%) had no complications described in the guideline; there was 1(1.6%) infection and 9(15%) experienced post-operative pain. Smokers 9(15%) needed more procedures than non-smokers (2.7 vs 1.8) and had less significant improvements (55.6% vs 68.2%). Smokers had more fat harvested (358mls vs 229mls) and more fat used (219mls:61.9% vs 142mls:60.3%). Patients with significant improvements had a larger fat volume harvested (255mls) and larger proportion used (174mls:63.6%). No local recurrence was recorded. Small group numbers limited statistical analysis. Conclusions: Our data agrees with current research, that smokers have worse outcomes. MDT consultation provides written information and thorough discussion by surgeons and breast care nurses but recorded with variability. Findings indicate broad adherence to guidance. The outcome for smokers raises questions about offering them lipomodelling and emphasises the need for smoking cessation advice in breast surgery units.
Topic: Surgical techniques
Introduction: After the introduction of Lipomodelling, a useful tool in the breast surgeon's armoury, in 2015, a service evaluation was undertaken using the joint Lipomodelling Guidelines for Breast Surgery (2012). Methods :Theatre diaries, 2015 to 2017, were used to identify patients who underwent lipomodelling. Patient's complete hospital records were reviewed. Results: 61 of 70 patients' data was available for review. Median age 53yrs (range20-76). 55(90%) underwent the procedure for cancer; 5(8%) for risk reduction; and 1(1.6%) for cosmesis. 24(39%) received written information. The median number of procedures was 2(range1-4). Younger patients underwent more procedures. (<39yrs:2.8; >60yrs:1.4). 53(87%) noted some improvement; 37(61%) significant improvement. 34(55.7%) had no complications described in the guideline; there was 1(1.6%) infection and 9(15%) experienced post-operative pain. Smokers 9(15%) needed more procedures than non-smokers (2.7 vs 1.8) and had less significant improvements (55.6% vs 68.2%). Smokers had more fat harvested (358mls vs 229mls) and more fat used (219mls:61.9% vs 142mls:60.3%). Patients with significant improvements had a larger fat volume harvested (255mls) and larger proportion used (174mls:63.6%). No local recurrence was recorded. Small group numbers limited statistical analysis. Conclusions: Our data agrees with current research, that smokers have worse outcomes. MDT consultation provides written information and thorough discussion by surgeons and breast care nurses but recorded with variability. Findings indicate broad adherence to guidance. The outcome for smokers raises questions about offering them lipomodelling and emphasises the need for smoking cessation advice in breast surgery units.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}